[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100642577":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":31,"locations":40,"responsibleParty":58,"collaborators":60,"id":70,"slug":71,"hasResults":72,"nctId":73,"briefTitle":74,"officialTitle":75,"acronym":12,"eligibilityCriteria":76,"healthyVolunteers":77,"sex":78,"minAge":79,"maxAge":80,"enrollmentInfo":81,"targetDuration":12,"studyType":84,"phases":85,"briefSummary":87,"conditions":88,"keywords":91,"overallStatus":98,"whyStopped":12,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":100,"startDateStruct":103,"completionDateStruct":105,"leadSponsor":107,"locationsCount":108},{"fullName":5,"class":6},"Johns Hopkins Bloomberg School of Public Health","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Standard of Care (SoC)","NO_INTERVENTION","Participants will receive standard of care (SoC) per Ministry of Health national guidelines of PrEP counseling, national program quality improvement activities, and follow up text messages and phone calls after missed visit.",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Tracing Strategy","ACTIVE_COMPARATOR","Participants will receive the SoC and tracing strategy to ascertain their PrEP outcome if they missed a visit.",[18],"Behavioral: Tracing Strategy",[20],{"type":21,"name":14,"description":22,"armGroupLabels":23,"otherNames":12},"BEHAVIORAL","Participants will receive the SoC per national guidelines and the tracing strategy. The purpose of this intervention is to ascertain the PrEP outcome of clients who have become LTFU (3 months late for a follow-up visit. The strategy includes 1) phone tracing and 2) field tracing with consent.",[14],[25,28],{"name":26,"affiliation":5,"role":27},"Sheree Schwartz, PhD, MPH","PRINCIPAL_INVESTIGATOR",{"name":29,"affiliation":30,"role":27},"Linda Nyondo-Mipando, PhD, RNM","Kamuzu University of Health Sciences",[32,37],{"name":33,"role":34,"phone":35,"phoneExt":12,"email":36},"Amal Abdulrahman, MSPH","CONTACT","+ 1 443-983-4376","aabdul23@jh.edu",{"name":26,"role":34,"phone":38,"phoneExt":12,"email":39},"+1 443-983-2464","sschwartz@jhu.edu",[41],{"facility":42,"status":12,"city":43,"state":12,"zip":12,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Johns Hopkins Research Project Malawi","Blantyre","Malawi","MW",{"type":47,"coordinates":48},"Point",[49,50],35.00854,-15.78499,{"lat":50,"lon":49},[53,57],{"name":54,"role":34,"phone":55,"phoneExt":12,"email":56},"Sufia Dadabhai, PhD, MHS","+265 111 811 885","sufia@jhu.edu",{"name":29,"role":27,"phone":12,"phoneExt":12,"email":12},{"type":59,"investigatorFullName":12,"investigatorTitle":12,"investigatorAffiliation":12,"oldNameTitle":12,"oldOrganization":12},"SPONSOR",[61,64,65,68],{"name":62,"class":63},"National Institute of Mental Health (NIMH)","NIH",{"name":30,"class":6},{"name":66,"class":67},"Johns Hopkins Research Project, Malawi","UNKNOWN",{"name":69,"class":6},"Washington University School of Medicine","100642577","betterinfo-on-womens-prep-choices-and-outcomes-in-malawi-100642577",false,"NCT07579754","BetterInfo on Women's PrEP Choices and Outcomes in Malawi","BetterInfo Tracing Approach to Evaluate HIV PrEP Choices and Use Over Time Among Women in Blantyre, Malawi","Inclusion Criteria:\n\nThe population for this research includes women aged 18 years or older at risk of HIV who initiated injectable or oral PrEP at one of the 20 Blantyre sites supported through PathToScale. PathToScale supports various types of facilities including public health clinics, drop-in centers for prioritized populations (DICs), and private hospitals\u002Fclinics.\n\nThose eligible for sampling are as follows:\n\n* Adult women ≥18 years; and\n* Initiated PrEP (injectable or oral) at the implementing facilities and lost to follow up within prior 2 years prior to sampling; and\n* Lost-to-follow-up (missed their PrEP visit by ≥3 months and for whom outcomes are unknown); and\n* Has a registered phone number for contact\n\nThose eligible for tracing are as follows:\n\n* Women sampled per eligibility criteria above; and\n* Women who have indicated permission for in-person follow-up\n\nHealth Care Providers, Implementing Partners, Ministry of Health (MOH) Stakeholers\n\n* providers and implementing partners from PathtoScale, and Ministry of Health stakeholders will be consented to participate in in-depth-interviews\n\nExclusion Criteria:\n\nThose excluded from sampling or tracing include:\n\n* Women who have an EMR record of a documented case of discontinuation of PrEP in consultation with a provider; or\n* Women who are known to have died; or\n* Women who have EMR documented transfers out of PathToScale supported facilities; or\n* Women refusing follow-up via phone on their ScanForm; or\n* Women refusing follow-up in person (during phone tracing); or\n* Women who do not speak Chichewa or English; or\n* Men (excluded from client interviews only)",true,"FEMALE","18 Years","110 Years",{"count":82,"type":83},384,"ESTIMATED","INTERVENTIONAL",[86],"NA","The purpose of this study is to understand PrEP user choices, preferences and implementation impact of the roll-out of long-acting injectable PrEP alongside oral PrEP among women in Blantyre, Malawi.",[89,90],"Long-acting Injectable Cabotegravir for PrEP","Oral Pre-Exposure Prophylaxis (PrEP)",[92,93,94,95,96,97],"Implementation Science","Long-acting injectable cabotegravir for PrEP","Oral pre-exposure prophylaxis (PrEP)","HIV","pre-exposure prophylaxis (PrEP)","Lost-to-follow up (LTFU)","NOT_YET_RECRUITING","2026-06-12",{"date":101,"type":102},"2026-06-15","ACTUAL",{"date":104,"type":83},"2026-06",{"date":106,"type":83},"2029-04",{"name":5,"class":6},1]